A randomized controlled clinical trial on efficacy and safety of anakinra in patients with severe COVID-19.
Kharazmi AB, Moradi O, Haghighi M, Kouchek M, Manafi-Rasi A, Raoufi M, Shoaei SD, Hadavand F, Nabavi M, Miri MM, Salarian S, Shojaei S, Khalili S, Sistanizad M, Sadeghi S, Karagah A, Asgari S, Jaffaraghaei M, Araghi S.
Kharazmi AB, et al. Among authors: kouchek m.
Immun Inflamm Dis. 2022 Feb;10(2):201-208. doi: 10.1002/iid3.563. Epub 2021 Nov 11.
Immun Inflamm Dis. 2022.
PMID: 34762351
Free PMC article.
Clinical Trial.